Show simple item record

dc.contributor.authorShihab, Hasan M
dc.contributor.authorLutwama, Fred
dc.contributor.authorPiloya, Theresa
dc.contributor.authorCastelnuovo, Barbara
dc.contributor.authorKambugu, Andrew D.
dc.contributor.authorColebunders, Robert
dc.date.accessioned2011-12-30T17:53:45Z
dc.date.available2011-12-30T17:53:45Z
dc.date.issued2009-03
dc.identifier.citationShihab, H.M., Lutwama, F., Piloya, T., Castelnuovo, B., Kambugu, A.D., Colebunders, R. (2009). Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause? Journal of Infection in Developing Countries, 3(5)en_US
dc.identifier.issn2036-6590
dc.identifier.urihttp://hdl.handle.net/10570/276
dc.descriptionCase reporten_US
dc.description.abstractA large number of patients are switched to second-line antiretroviral therapy, especially in resource limited settings. Lopinavir/Ritonavir is the main drug used in second-line treatment regimens. We describe a patient attending an HIV treatment centre in Kampala, Uganda, who presented with bilateral non-tender pitting inflammatory edema two weeks after switching to a Lopinavir/Ritonavir-containing second-line treatment regimen. The lack of an alternate explanation led us to suspect that Lopinavir/Ritonavir was potentially responsible for the edemaen_US
dc.language.isoenen_US
dc.publisherOpen Learning on Enteric Pathogensen_US
dc.subjectEdemaen_US
dc.subjectLopinavir/Ritonaviren_US
dc.subjectResource-limited settingsen_US
dc.subjectHIV/AIDSen_US
dc.subjectUgandaen_US
dc.subjectAntiretroviral therapyen_US
dc.titleBilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause?en_US
dc.typeJournal article, peer revieweden_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record